Jurnal Kesehatan Farmasi publishes scholarly manuscripts that contribute to the advancement of knowledge in pharmacy and pharmaceutical sciences. The journal welcomes empirical, theoretical, methodological, and evidence-synthesis contributions relevant to its Aim and Scope.

Topics include pharmaceutics and pharmaceutical technology; pharmaceutical chemistry and analysis; pharmacology and toxicology; pharmacognosy and natural products; clinical pharmacy and pharmaceutical care; community and hospital pharmacy; pharmacy practice and education; drug utilization and medication adherence; drug safety and pharmacovigilance; formulation and evaluation of medicines and health products; quality assurance and quality control; pharmaceutical microbiology and biotechnology; regulatory affairs and pharmaceutical policy; and public health topics related to medicines and pharmacy.

Jurnal Kesehatan Farmasi encourages interdisciplinary scholarship connecting pharmacy with clinical practice, public health, biomedical science, and healthcare systems. Contributions should promote scientific rigor, research integrity, patient safety, ethical conduct, and responsible dissemination of pharmaceutical and health-related knowledge.

All manuscripts must be original, scientifically rigorous, ethically conducted, relevant to the journal’s scope, written in English, and prepared in accordance with Jurnal Kesehatan Farmasi Author Guidelines and Publication Ethics. Submissions are subject to editorial assessment and, where applicable, peer review.

1. Original Research Article

Original Research Articles report original and previously unpublished empirical research that makes a substantive contribution to pharmacy or pharmaceutical sciences.

Jurnal Kesehatan Farmasi welcomes research employing quantitative, qualitative, or mixed-methods approaches, including laboratory experiments, formulation and evaluation studies, analytical method validation, observational studies, clinical or community-based studies, surveys, pharmacoepidemiology, qualitative interviews, database analysis, and other scientifically appropriate designs.

An Original Research Article should generally include:

1. Abstract and Keywords;
2. Introduction;
3. Methods;
4. Results;
5. Discussion;
6. Conclusion; and
7. References.

The Results and Discussion sections may be combined where appropriate to the research approach and journal guidelines.

Authors should clearly explain the research problem, theoretical framework, research design, data sources, sampling or case-selection procedures, and analytical methods. Studies involving human participants must comply with applicable research ethics requirements, including informed consent, confidentiality, and ethical approval where required.

2. Systematic Review and Meta-Analysis

Systematic Review articles provide a rigorous and transparent synthesis of existing research addressing a clearly formulated question relevant to pharmacy, pharmaceutical sciences, medicines, or pharmacy practice.

This category includes systematic reviews, systematic reviews with meta-analysis, meta-analyses, scoping reviews, mapping reviews, and qualitative evidence syntheses, where appropriate.

Authors should clearly describe:

• the research question and review objectives;
• eligibility criteria;
• databases and other information sources;
• search strategies and search dates;
• study-selection procedures;
• data-extraction procedures;
• assessment of methodological quality or risk of bias, where applicable; and
• methods of analysis and evidence synthesis.

Reviews should critically assess the strength, limitations, and contextual relevance of the available evidence. Systematic reviews should follow recognized reporting standards appropriate to the review design, such as PRISMA, where applicable.

3. Review Article

Review Articles provide comprehensive, critical, and balanced analyses of established or emerging topics in pharmacy and pharmaceutical sciences.

A Review Article should go beyond a descriptive summary of previous publications. Authors are expected to synthesize relevant scholarship, examine theoretical and empirical debates, evaluate major developments, identify research gaps, and propose directions for future investigation.

Relevant topics may include drug discovery and development, dosage-form design, pharmaceutical analysis, natural products, pharmacological mechanisms, medication safety, clinical pharmacy, pharmaceutical care, drug utilization, pharmacovigilance, regulatory science, and other issues within the journal’s scope.

Review Articles should generally contain:

1. Abstract and Keywords;
2. Introduction;
3. Relevant Thematic or Conceptual Subsections;
4. Critical Discussion;
5. Conclusion; and
6. References.

Authors should explain the scope and basis of literature selection sufficiently to make the review’s coverage and limitations clear.

4. Conceptual and Theoretical Article

Conceptual and Theoretical Articles develop, examine, integrate, or critically evaluate concepts, theories, analytical frameworks, models, or propositions relevant to pharmacy and pharmaceutical sciences.

These contributions may address pharmaceutical care models, rational medicine use, medication adherence, pharmacoeconomics, pharmaceutical policy, drug safety, quality systems, formulation science, drug delivery, and related areas.

Manuscripts should present a clear and original scholarly argument. Authors are expected to establish the conceptual foundations of their analysis, engage critically with relevant literature, consider competing explanations, and explain the contribution of the proposed argument or framework.

Conceptual and Theoretical Articles may propose:

• new pharmaceutical or pharmacy-practice concepts;
• theoretical models and propositions;
• integration or reinterpretation of existing theories;
• critical evaluations of established frameworks; and
• context-sensitive explanations of pharmaceutical or medication-related phenomena.

Arguments should be logically developed and supported by appropriate scholarship. Where relevant, authors should explain how the proposed framework could inform empirical research, pharmaceutical policy, patient care, or professional practice.

5. Methods and Measurement Article

Methods and Measurement Articles present significant methodological developments relevant to pharmacy and pharmaceutical sciences.

These may include:

• development and validation of research instruments;
• development and validation of analytical methods for pharmaceutical substances and products;
• development and validation of clinical, pharmacy-practice, or medication-use instruments;
• evaluation of pharmaceutical quality attributes and performance tests;
• experimental design and statistical methods for pharmaceutical research;
• laboratory, clinical, and mixed-methods innovations;
• computational approaches in drug discovery, formulation, or pharmacokinetic analysis;
• methods for pharmacovigilance, pharmacoepidemiology, and medication-use evaluation; and
• adaptation and validation of measurement instruments for pharmacy and healthcare settings.

Manuscripts should clearly identify the methodological problem, explain the proposed approach, and demonstrate its value through appropriate empirical evidence, applications, simulations, or worked examples.

Instrument and index studies should explain the conceptual basis, item or indicator selection, data sources, analytical procedures, and relevant evidence of reliability and validity.

Particular attention should be given to the scientific validity, reproducibility, suitability, and practical application of methods and measurements in pharmaceutical and healthcare settings. Authors should address data integrity, quality assurance, patient or participant protection, and ethical considerations where applicable.

6. Brief Research Report

Brief Research Reports present original pharmaceutical research or significant preliminary findings in a concise format.

Suitable contributions may include focused studies of preliminary formulation results, pharmaceutical quality testing, analytical method performance, drug utilization, medication safety, pharmacological screening, natural products, pharmacy services, or other issues within the journal’s scope.

These manuscripts must maintain the same standards of scientific rigor, research ethics, transparency, and methodological quality expected of full Original Research Articles. Preliminary findings should be explicitly identified, with appropriate limits placed on their interpretation.

A Brief Research Report should generally include:

1. Abstract and Keywords;
2. Introduction;
3. Methods;
4. Results;
5. Discussion and/or Conclusion; and
6. References.

The shorter format should not omit essential information required to assess the credibility of the research. Authors should clearly explain the study’s contribution, limitations, and implications.

7. Perspective

Perspective Articles present scholarly viewpoints on important, emerging, or contested issues in pharmacy and pharmaceutical sciences.

These articles may examine medicine development, rational drug use, pharmaceutical care, antimicrobial resistance, medication safety, pharmacy education, regulatory developments, access to medicines, digital pharmacy, or other relevant topics.

Perspectives should be evidence-based, analytically clear, academically balanced, and properly referenced. Authors should engage with relevant scholarship and competing viewpoints while clearly distinguishing established evidence, scholarly interpretation, and normative arguments.

A Perspective Article should offer a substantive contribution to academic debate. Unsupported opinion, partisan promotion, and commentary without adequate scholarly grounding do not meet the requirements of this article type.

Interdisciplinary and Contextual Perspectives in Pharmacy and Pharmaceutical Sciences

Jurnal Kesehatan Farmasi recognizes that pharmaceutical research and pharmacy practice are shaped by clinical, cultural, institutional, regulatory, economic, and geographical contexts. Accordingly, the journal encourages scholarship that examines these contexts explicitly and avoids unwarranted generalization beyond the evidence or setting studied.

Jurnal Kesehatan Farmasi encourages authors to:

• incorporate local, national, international, or comparative perspectives where relevant;
• consider differences in healthcare systems, medicine availability, clinical settings, and pharmacy services;
• account for relevant patient, professional, institutional, and regulatory factors in research design and interpretation;
• protect patient safety, privacy, dignity, and rights;
• evaluate the contextual relevance of theories, methods, and measurement tools;
• distinguish empirical findings from interpretation and recommendations;
• promote responsible exchange and dissemination of pharmaceutical knowledge; and
• develop interdisciplinary dialogue that strengthens pharmaceutical research and pharmacy practice.

Jurnal Kesehatan Farmasi welcomes studies conducted in Indonesia and other countries, including comparative and multicenter research. Contributions should explain how their findings advance broader pharmaceutical knowledge while remaining attentive to the specific settings in which the research was conducted.

The journal particularly encourages research addressing underserved populations and regions, including studies of access to medicines, barriers to pharmaceutical care, medicine safety, and differences in healthcare and pharmacy services.

Research involving patients, vulnerable populations, investigational medicines, or sensitive health information should use precise terminology, avoid stigmatizing generalizations, and explain measures to protect participants, confidential data, and safety.

Editorial Consideration

Acceptance of an article type does not guarantee publication. All submissions are initially assessed for relevance to the Aim and Scope of Jurnal Kesehatan Farmasi, originality, academic quality, methodological adequacy, ethical compliance, and contribution to the literature.

The Editorial Team reserves the right to recommend reclassification when a manuscript’s content, methodology, or scholarly contribution does not correspond to the article type selected during submission.

Authors must ensure that their manuscripts are written in English and comply with the journal’s Author Guidelines before submission.